|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study显示文摘 | Hedy L Kindler Tatsuya Ioka Dirk J Richel Jaafar Bennouna Richard Létourneau Takuji Okusaka Akihiro Funakoshi Junji Furuse Young Suk Park Shinichi Ohkawa Gregory M Springett Harpreet S Wasan Peter C Trask Paul Bycott Alejandro D Ricart Sinil Kim Eric Van | 2011 | Lancet Oncology2011，，3： | 4 |
| 2 | Randomized phase Ⅱ trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study显示文摘 | SALTZ L B LENZ H J KINDLER H L | 2007 | J Clin Oncol2007，25，29： | 1 |
| 3 | The stratigraphy and surficial geology of New Providence and surrounding islands, Bahamas显示文摘 | Hearty P J Kindler P | 1997 | Journal of Coastal Research1997，13，： | 1 |
| 4 | Theta burst transcranial magnetic stimulation for the treatment of auditory verbal hallucinations: results of a randomized controlled study显示文摘 | Kindler J Homan P Flury R | 2013 | Psychiatry Res2013，209，1： | 1 |
| 5 | Theta burst stimu- induces improvement in aphasic patients 显示文摘 | Kindler J lation over of naming Schumacher R Cazzoli D et the right Broca's homologue al | 2012 | Stroke2012，43，8： | 1 |
| 6 | Russian wheat aphid resistance in cool-season grasses显示文摘 | Kindler D Breen J P Spinger T | 1990 | Journal of Economic Entomology1990，84，： | 1 |
| 7 | The role of gemcitabine in the treatment of malignant mesothelioma显示文摘 | KINDLER H L van MEERBEECK J P | 2002 | Semin Oncol2002，29，1： | 1 |
| 8 | Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study显示文摘 | Kindler HL Ioka T Richel D J | 2011 | Lancet Oncol2011，12，3： | 1 |
| 9 | The Petri Net Markup Language显示文摘 | J Weber E Kindler | 2003 | Lecture Notes in Computer Science2003，2472，： | 1 |
| 10 | A pla- cebo-controlled, randomized phase Ⅱ study of conatumumab (C) or AMG 479 (A) or placebo (P) plus gemcitabine (G) in pa- tients (pts) with metastatic pancreatic cancer ( mPC ) 显示文摘 | KINDLER HL RICHARDS DA STEPHENSON J | 2010 | J Clin Oncol2010，28，15： | 1 |
| 11 | Phase I trial of orally administered CEP-701 ,a novel neurotrophin receptor-linked tyrosine kinase inhibitor显示文摘 | Marshall JL Kindler H Deeken J | 2005 | Invest New Drugs2005，23，1： | 1 |
| 12 | Topological Intersection Theorems 显示文摘 | Kindler J | 1993 | Proc Amer Math Soc1993，117，4： | 1 |
| 13 | Axitinib plus gem- citabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double- blind randomised phase 3 study显示文摘 | Kindler HL Ioka T Richel D J | 2011 | Lancet Oncol2011，12，3： | 1 |
| 14 | Axitinib plus gem- citabine versus placebo plus gemcitabine in patients with ad- vanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study 显示文摘 | Kindler HL Ioka T Richel D J | 2011 | Lancet Oncol2011，12，3： | 1 |
| 15 | Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor显示文摘 | Marshall JL Kindler H Deeken J | 2005 | Invest New Drugs2005，23，1： | 1 |
| 16 | A +20 m middle Pleistocene sea level highstand (Bermuda and the Bahamas) due to partial collapse of Antarctic ice显示文摘 | Hearty P J Kindler P Chen H | 1999 | Geology1999，27，： | 1 |
| 17 | Antieancer activity of the type I insulin-like growth factor receptor antagonist, ganitum- ab, in combination with the death receptor 5 agonist, eonatu- mumab显示文摘 | Tabernero J Chawla SP Kindler H | 2015 | Target Oncol2015，10，1： | 1 |
| 18 | A phase Ib study to evaluate the safety and efficacy of AMG 655 in combination with gemcitabine in patients with metastatic pancreatic cancer显示文摘 | Kindler HL Garbo L Stephenson J | 2009 | J Clin Oncol2009，27，： | 1 |
| 19 | Randomized phase II trial of cetuximab,bevacizumab,and irinotecan compared with cetuximab and bevacizumab alone in irinotecan refractory colorectal cancer:the BOND-2study显示文摘 | SALTZL B LENZ H J KINDLER H L | 2007 | J Clin Oncol2007，25，29： | 1 |
| 20 | Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study 显示文摘 | Saltz LB Lenz H J Kindler HL | 2007 | J Clin Oncol2007，25，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员